谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

LBA27 Erdafitinib (ERDA) or ERDA Plus Cetrelimab (CET) for Patients with Metastatic or Locally Advanced Urothelial Carcinoma (muc) and Fibroblast Growth Factor Receptor Alterations (fgfra): First Phase (ph) II Results from the NORSE Study

T. B. Powles, V. Chistyakov, V. Beliakouski,A. Semenov, E. Everaert,Y. Baranau,V. Moreno,B. Perez Valderrama,Y. Vano,G. Del Conte,Y. Loriot,T. W. Kang,M. Tammaro,A. O'Hagan, M. Hosseini,S. Triantos,H. Chhabra,A. Santiago-Walker,A. O. Siefker-Radtke

Annals of Oncology（2021）

引用 13|浏览28
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要